FAKTOR-OPTIONSSCHEIN - IPSEN | Market Closed - Börse Stuttgart 09:22:57 11/06/2024 BST | ||
| 15.96 EUR | +2.18% |
|
| Current month | +8.72% | ||
| 1 month | +12.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 11/06/24 | 15.96 | +2.18% |
| 10/06/24 | 15.62 | +0.51% |
| 07/06/24 | 15.54 | -0.06% |
| 06/06/24 | 15.55 | -0.70% |
| 05/06/24 | 15.66 | +3.50% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 09:22 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG156D |
| ISIN | DE000MG156D3 |
| Date issued | 27/03/2024 |
| Strike | 90.69 € |
| Maturity | Unlimited |
| Parity | 2.07 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.06 € |
|---|---|
| Lowest since issue | 8.83 € |
| Spread | 0.07 € |
| Spread % | 0.47% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.9
EUR
Average target price
127
EUR
Spread / Average Target
+5.07%
- Stock Market
- Certificates
- Certificat